Lost password ?
<< Back to Equity Research
UNIMED
UNIMED, AN ATTRACTIVENESS CALLED INTO QUESTION
Jun 09 - The performance of Pharma sector listed on Tunisian stock exchange and covered by AlphaMena (3 stocks, a €111m market cap) since the beginning of the year has not exceeded 5% on average. The current ...
Executive summary
Conflict of Interest
Pages 34
Language English
Publish on June 9, 2020
€ 500
VAT Exl.
You might be also interested by these reports :
Apr 15 PM
Idea Kicker
JULPHAR, WAITING FOR A SAFETY MARGIN
Mar 19 AM
Gulf Pharmaceutical
A better Q4 lifted our Target Price
Mar 16 PM
Gulf Pharmaceutical
A hit from outside GCC revenues in 2023
Mar 04 PM
Gulf Pharmaceutical
Modest 2023 results despite a better-than-expected Q4
FIND A REPORT
CONCEPT
Each company is researched in depth using a structured robust and transparent process.

AlphaMena provides analyses based upon exhaustive and homogeneous information which allows to compare stocks geographically, sector-wise, and by thematic.

The analyses include actuarial as well as off balance-sheet data.
BloombergStarmineFactsetReutersCapital IQ